(Q36882492)

English

Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial

scientific article published on August 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

phase III clinical trial

0 references

Charles M. Balch

5

object named as

Balch CM

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

author name string

Wallack MK

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sivanandham M

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Ditaranto K

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Shaw P

4

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Urist MM

6

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Bland KI

7

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Murray D

8

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Robinson WA

9

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Flaherty L

10

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Richards JM

11

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Rosen L

12

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Bartolucci AA

13

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

language of work or name

0 references

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Annals of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

226

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

198-206

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Immunotherapy of Malignant Melanoma With Vaccinia Virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A preliminary trial of vaccinia oncolysates in the treatment of recurrent melanoma with serologic responses to the treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active specific immunotherapy in malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach in specific, active immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9296514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/00000658-199708000-00012

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36882492&oldid=2088154973"